Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of changes to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 5069

Previous 25           Next 25
Website Changes
07/24/2020 FDA Grants Rare Pediatric Disease Designation to ONC201 for the Treatment of H3 K27M-Mutant Glioma
07/24/2020 Trump administration unveils four executive orders aimed at lowering drug prices
07/22/2020 GBM awareness day: Contact your legislators!
07/22/2020 First Recurrent GBM Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays
07/11/2020 Comparative Epidemiology of Gliosarcoma and Glioblastoma and the Impact of Race on Overall Survival: A Systematic Literature Review
07/09/2020 Ziopharm Oncology Doses First DIPG Patient in Phase 1/2 Trial of Controlled IL-12 for the Treatment of Pediatric Brain Tumors
07/08/2020 Musella Foundation awards another brain tumor research grants!
07/07/2020 Survival, Costs, and Health Care Resource Use by Line of Therapy in US Medicare Patients With Newly Diagnosed Glioblastoma: A Retrospective Observational Study
07/03/2020 Everolimus improves the efficacy of dasatinib in PDGFRa-driven glioma
07/03/2020 Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients
07/03/2020 Is polio the answer to curing brain tumors?
07/01/2020 Early Imaging Marker of Progressing Glioblastoma: A Window of Opportunity
06/30/2020 Musella Foundation awards two more brain tumor research grants!
06/29/2020 First annual Dragon Derby!
06/29/2020 We need your supprt for the Promising Pathway Act
06/29/2020 A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study
06/28/2020 David Zagzag, MD, Ph.D. Recognized as a Professional of the Year for 2020 by Strathmore`s Who`s Who Worldwide
06/27/2020 ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP
06/25/2020 A Systematic Review of Tumor Treating Fields Therapy for High-Grade Gliomas
06/24/2020 Musella Foundation Copay Program now closed to new patients
06/24/2020 New class of precision medicine strips cancer of its DNA defenses
06/24/2020 DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II
06/22/2020 Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease
06/21/2020 Brain Tumor Webinars continue tonight! Sunday 6/21/2020 7pm Eastern Time
06/18/2020 Gallagher, Colleagues Introduce Bipartisan Promising Pathways Act



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740